Evaluation of Microhematuria: A Risk-based Approach - Frankly Speaking Ep 199

Credits: 0.25 AMA PRA Category 1 Credits™

Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-199

Overview: Microhematuria is a common finding. It is usually benign, but it needs proper evaluation since it may also be a sign of malignancy. A risk-based approach can avoid unnecessary testing, while still identifying those patients with malignancy. Recent American Urological Association (AUA) guidelines use a validated risk-based approach.

Guest: Alan Ehrlich, MD

Music Credit: Richard Onorato